S 3788 · 119th Congress · Health
CLEAR LABELS Act
Bill Progress
✓
Introduced2
Committee3
Senate Vote4
House5
EnactedLatest: Committee on Health, Education, Labor, and Pensions. Hearings held.(2026-03-19)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 3788 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 3788 To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES February 5, 2026 Mr. Scott of Florida (for himself, Mrs. Gillibrand, Mr. Tuberville, Mrs. Britt, and Mr. Johnson) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act'' or the ``CLEAR LABELS Act''. SEC. 2. REQUIRE DRUG LABELING TO I…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (11)
1 Democrat10 Republicans